Key facts
- NuboMed’s last known valuation is $154.4M (Feb 2021).
- It has raised $30.9M; the latest was Later Stage VC in Jul 2025.
- Notable investors include SAIF Partners, DT Lake Equity Investment, Juffett Investment, Shenzhen Bridge Capital, Shenzhen HTI Group — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for NuboMed
- ·The full record, as it builds
Funding rounds
No funding rounds for NuboMed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NuboMed
Developer of integrated software and hardware systems designed for the medical sector, focusing on intelligent hospital IoT management and comprehensive medication and material tracking. The company's offerings include hospital IoT integration platforms, medication management systems, inventory tracking tools, automated dispensing units and logistics coordination modules, enabling healthcare facilities to improve operational efficiency and streamline supply chains from suppliers to patients.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2012
- Employees
- 400
- Website
- nubomed.com/
- Ownership
- Privately Held (backing)
NuboMed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NuboMed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NuboMed in its N-PORT filings yet. We sweep new filings monthly.